5:09 PM ET
10-Q
Financial Results
Celularity Q2 2026 Results: Turns Profitable, Net Income $706K
Celularity Inc. reported a significant decrease in cash and cash equivalents from $6.18 million at the end of 2025 to $586,000 as of June 30, 2026. The company's total assets declined to $96.2 million, while it continues to focus on cellular therapy development and commercializing its biomaterials products.
- Key figure
- Net income $706K